CEFIXIME is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Cefixime.
Product ID | 70518-3221_cbfb2cd6-1a28-3dc5-e053-2995a90a6d3f |
NDC | 70518-3221 |
Product Type | Human Prescription Drug |
Proprietary Name | CEFIXIME |
Generic Name | Cefixime |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2021-09-14 |
Marketing Category | NDA AUTHORIZED GENERIC / |
Application Number | NDA203195 |
Labeler Name | REMEDYREPACK INC. |
Substance Name | CEFIXIME |
Active Ingredient Strength | 400 mg/1 |
Pharm Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2021-09-14 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
16714-766 | Cefixime | cefixime |
16714-767 | Cefixime | cefixime |
43598-673 | Cefixime | Cefixime |
43598-674 | Cefixime | Cefixime |
62250-663 | Cefixime | cefixime |
62250-664 | Cefixime | cefixime |
67877-584 | CEFIXIME | CEFIXIME |
68180-416 | CEFIXIME | CEFIXIME |
68180-405 | CEFIXIME | CEFIXIME |
68180-407 | CEFIXIME | CEFIXIME |
62250-668 | Cefixime | Cefixime |
65862-751 | Cefixime | Cefixime |
65862-752 | Cefixime | Cefixime |
68180-423 | CEFIXIME | CEFIXIME |
70518-2749 | CEFIXIME | CEFIXIME |
27437-201 | SUPRAX | cefixime |
27437-203 | SUPRAX | cefixime |
27437-205 | SUPRAX | cefixime |
27437-206 | SUPRAX | cefixime |
27437-207 | SUPRAX | cefixime |
27437-208 | SUPRAX | cefixime |
43063-537 | SUPRAX | cefixime |
54348-797 | SUPRAX | CEFIXIME |